» Articles » PMID: 28280464

Endogenous Leucine-Rich Repeat Kinase 2 Slows Synaptic Vesicle Recycling in Striatal Neurons

Overview
Date 2017 Mar 11
PMID 28280464
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Dominant mutations in leucine-rich repeat kinase 2 (LRRK2) produce the most common inherited form of Parkinson's disease (PD) but the function of LRRK2 remains poorly understood. The presynaptic role of multiple genes linked to PD including α-synuclein (α-syn) has suggested that LRRK2 may also influence neurotransmitter release, a possibility supported by recent work. However, the use of disease-associated mutants that cause toxicity complicates the analysis. To determine whether LRRK2 normally influences the synaptic vesicle, we have now used a combination of imaging and electrophysiology to study LRRK2 knockout (KO) mice. Surprisingly, we find that in hippocampal (generally excitatory) neurons, the loss of LRRK2 does not affect synaptic vesicle exocytosis, endocytosis or the mobility of α-syn. Double KO (DKO) mice lacking LRRK1 as well as LRRK2 also show no defect in transmitter release by hippocampal neurons. However, in striatal neurons, which express LRRK2 at higher levels, the loss of LRRK2 leads to modest acceleration of synaptic vesicle endocytosis. Thus, endogenous LRRK2 normally slows synaptic vesicle recycling at striatal terminals.

Citing Articles

Disruption of Dopamine Homeostasis Associated with Alteration of Proteins in Synaptic Vesicles: A Putative Central Mechanism of Parkinson's Disease Pathogenesis.

Jin X, Si X, Lei X, Liu H, Shao A, Li L Aging Dis. 2023; 15(3):1204-1226.

PMID: 37815908 PMC: 11081171. DOI: 10.14336/AD.2023.0821-2.


Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine.

De Iuliis A, Montinaro E, Fatati G, Plebani M, Colosimo C Neural Regen Res. 2021; 17(3):523-533.

PMID: 34380882 PMC: 8504381. DOI: 10.4103/1673-5374.320965.


LRRK2 and the Endolysosomal System in Parkinson's Disease.

Erb M, Moore D J Parkinsons Dis. 2020; 10(4):1271-1291.

PMID: 33044192 PMC: 7677880. DOI: 10.3233/JPD-202138.


A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2.

Kuhlmann N, Milnerwood A Front Mol Neurosci. 2020; 13:153.

PMID: 32973447 PMC: 7482583. DOI: 10.3389/fnmol.2020.00153.


The Role of Human LRRK2 in Methylmercury-Induced Inhibition of Microvesicle Formation of Cephalic Neurons in Caenorhabditis elegans.

Ke T, Santamaria A, Rocha J, Tinkov A, Lu R, Bowman A Neurotox Res. 2020; 38(3):751-764.

PMID: 32725544 PMC: 7484354. DOI: 10.1007/s12640-020-00262-5.


References
1.
Li Y, Liu W, Oo T, Wang L, Tang Y, Jackson-Lewis V . Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci. 2009; 12(7):826-8. PMC: 2845930. DOI: 10.1038/nn.2349. View

2.
Santos M, Park C, Foss S, Li H, Voglmaier S . Sorting of the vesicular GABA transporter to functional vesicle pools by an atypical dileucine-like motif. J Neurosci. 2013; 33(26):10634-46. PMC: 3693053. DOI: 10.1523/JNEUROSCI.0329-13.2013. View

3.
Li X, Patel J, Wang J, Avshalumov M, Nicholson C, Buxbaum J . Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J Neurosci. 2010; 30(5):1788-97. PMC: 2858426. DOI: 10.1523/JNEUROSCI.5604-09.2010. View

4.
Sweet E, Saunier-Rebori B, Yue Z, Blitzer R . The Parkinson's Disease-Associated Mutation LRRK2-G2019S Impairs Synaptic Plasticity in Mouse Hippocampus. J Neurosci. 2015; 35(32):11190-5. PMC: 4532754. DOI: 10.1523/JNEUROSCI.0040-15.2015. View

5.
Arranz A, Delbroek L, Van Kolen K, Guimaraes M, Mandemakers W, Daneels G . LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism. J Cell Sci. 2014; 128(3):541–52. DOI: 10.1242/jcs.158196. View